Predicting liver failure following major hepatectomy

Digestive and Liver Disease

Volumn 41, Issue 11, 2009, Pages 798-806

  Garcea, G ^a   Ong, S L ^a   Maddern, G J ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Childs Pugh; Failure; Hepatectomy; Indocyanine green; Liver; Scintigraphy; Surgery

Indexed keywords

ACYLTRANSFERASE; ASIALOGLYCOPROTEIN RECEPTOR; DEETHYLLIDOCAINE; GALACTOSE; HYALURONIC ACID; INDOCYANINE GREEN; LIDOCAINE; PREALBUMIN; RETINOL BINDING PROTEIN; SCATTER FACTOR;

CLINICAL ASSESSMENT TOOL; COMPUTER ASSISTED TOMOGRAPHY; HEPATOBILIARY SCINTISCANNING; HUMAN; LIVER CELL; LIVER CIRRHOSIS; LIVER FAILURE; LIVER METABOLISM; LIVER RESECTION; LIVER SIZE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SHORT SURVEY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ALBUMINS; BIOLOGICAL MARKERS; HEPATECTOMY; HUMANS; INDOCYANINE GREEN; LIVER FAILURE; LIVER FUNCTION TESTS; LIVER NEOPLASMS; ORGANOTECHNETIUM COMPOUNDS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 70349772184     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2009.01.015     Document Type: Short Survey

References (104)

1. Garden O.J., Rees M., Poston G.J., Mirza D., Saunders M., Ledermann J., et al. Guidelines for resection of colorectal cancer liver metastases. Gut 55 (2008) iii1-iii8
2. Pawlik T.M., Schulick R.D., and Choti M.A. Expanding criteria for resectability of colorectal liver metastases. Oncologist 13 (2008) 51-64
3. Farges O., Belghiti J., and Kianmanesh R. Portal vein embolisation before right hepatectomy: prospective clinical trial. Ann Surg 237 (2003) 208-217
4. Madoff D.C., Hicks M.E., and Abdalla E.K. Portal vein embolisation with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy. Safety and effectiveness: study in 26 patients. Radiology 227 (2003) 251-260
5. Vauthey J.N., Chaoui A., Do K.A., Bilimoria M.M., Fernstermacher M.J., Charsangavej C., et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 127 (2000) 512-519
6. Chun Y.S., Vauthey J.N., Ribero D., Donadon M., Mullen J.T., Eng C., et al. Systemic chemotherapy and two-stage hepatectomy for extensive bi-lateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg 11 (2007) 498-504
7. Lygidakis N.J., Bhagat A.D., Vrachnos P., and Grigorakakos L. Challenges in everyday surgical practice: a synchronous bi-lobar hepatic colorectal metastases: newer multimodality approach. Hepatogastroenterology 54 (2007) 1020-1024
8. Togo S., Nagano K., Masui H., Tanaka K., Miura Y., Morioka D., et al. Two-stage hepatectomy for multiple bi-lobar liver metastases from colorectal cancer. Hepatogastroenterology 52 (2005) 913-919
9. Wu C.C., Ho W.L., Lin M.C., Tang J.S., Yeh D.C., Liu T.J., et al. Is hepatic resection absolutely contraindicated for hepatocellular carcinoma in Child-Pugh class C cirrhotic patients?. Hepatogastroenterology 46 (1999) 635-639
10. Huo T., Lee S., and Lin H. Selecting an optimal prognostic scoring system for liver cirrhosis: the model for end-stage liver disease and beyond. Liver Int (2008) 606-613
11. Abdalla E.K., Denys A., Chevalier P., Nemr R.A., and Vauthey J.N. Total and segmental liver volume variations: implications for surgery. Surgery 135 (2004) 404-410
12. Sanrasgearan K., Kwo P.W., DiGirolamo D., Stockberger M., Cummings O.W., and Kopecky K.K. Measurement of liver volume using spiral CT and the curved line and cubic line algorithms: reproducibility and inter-observer variation. Abdom Imaging 24 (1997) 61-65
13. Shoup M., Gonen M., D'Angelica M., Jarnagin W.R., DeMatteo R.P., Schwartz L.H., et al. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 7 (2003) 325-330
14. Truant S., Oberlin O., Sergent G., Lebuffe G., Gambiez L., Ernst O., et al. Remnant liver volume to body weight ratio of > or =0.5: a new cut-off to estimate postoperative risks after extended resection in non-cirrhotic liver. J Am Coll Surg 204 (2007) 22-33
15. Dinanat S., de Graaf W., Verwer B.J., Bennink R.J., van Lienden K.P., Gouma D.J., et al. Risk assessment of post-hepatectomy liver failure using hepatobiliary scintigraphy and CT volumetry. J Nucl Med 48 (2007) 685-692
16. Ferrero A., Vigano L., Polastri R., Murartore A., Eminefendic H., Regge D., et al. Postoperative liver dysfunction and future liver remnant: where is the limit? Results of a prospective study. World J Surg 31 (2007) 1643-1651
17. Lamade W., Glombitza G., Fischer L., Chiu P., Cardenas Ce., Thorn M., et al. The impact of 3-dimensional reconstructions on operation planning in liver surgery. Arch Surg 135 (2000) 1256-1261
18. Rau H.G., Schauer R., Helmberger T., Holznecht N., Ruckmann B., Meyer L., et al. Impact of virtual reality imaging on hepatic liver tumour resection: calculation of risk. Langenbeck's Arch Surg 385 (2000) 162-170
19. Saito S., Yamanaka J., Miura K., Nakao N., Nagao T., Surgimoto T., et al. A novel 3D hepatectomy simulation based on liver circulation: application to liver resection and transplantation. Hepatology 41 (2005) 1297-1304
20. Schindl M.J., Redhead D.N., Fearon K.C., Garden O.J., and Wigmore S.J. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 54 (2004) 289-296
21. Shirabe K., Shimada M., Gion T., Hasegawa H., Takenaka K., Utsunomiay T., et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg 188 (1999) 304-309
22. Soyer P., Roche A., Moustafa G., Shapeero L., Brettmayer F., Elias D., et al. Preoperative segmental localization of hepatic metastases: utility of three-dimensional CT during arterial portography. Radiology 180 (1999) 653-658
23. Tu R., Xia L., Yu A., and Wu L. Assessment of hepatic functional reserve by cirrhosis grading and liver volume measurement using CT. World J Gastroenterol 13 (2007) 3956-3961
24. Yamanaka J., Saito S., and Fujimoto J. Impact of preoperative planning using virtual segmental volumetry on liver resection for hepatocellular carcinoma. World J Surg 31 (2007) 1249-1255
25. Maraescaux J., Clement J., Tassetti V., Koehl C., Cotin S., Russier Y., et al. Virtual reality applied to hepatic surgery simulation: the next revolution. Ann Surg 228 (1998) 627-634
26. Dello S.A., van Dam R.M., Siangen J.J., van de Poll M.C., Bemelmans M.H., Greve J.W., et al. Liver volumetry plug and play: do it yourself with ImageJ. World J Surg 31 (2007) 2215-2221
27. Lu Y., Wu Z., Liu C., and Wang H. Hepatic volumetry with Photoshop in personal computer. Hepatobiliary Pancreatic Dis Int 3 (2004) 82-85
28. Wakabayashi H., Nishiyama Y., Ushiyama T., Maeba T., and Maeta H. Evaluation of the effect of age on functioning hepatocyte mass and liver blood flow using liver scintigraphy in preoperative estimation for surgical patients: comparison with CT volumetry. J Surg Res 106 (2002) 246-253
29. Faybik P., and Hetz H. Plasma disappearance rate of indocyanine green in liver dysfunction. Transpl Proc 38 (2006) 801-802
30. Hashimoto M., and Watanabe G. Hepatic parenchymal cell volume and the indocyanine green tolerance test. J Surg Res 92 (2000) 222-227
31. Chijiiwa K., Watanabe M., Nakano K., Noshiro H., and Tanaka M. Biliary indocyanine green excretion as a predictor of hepatic adenosine triphosphate levels in patients with obstructive jaundice. Am J Surg 179 (2000) 161-166
32. Lam C.M., Fan S.T., Lo M., and Wong J. Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test. Br J Surg 86 (1999) 1012-1017
33. Sugimoto H., Okochi O., Hirota M., Kanazumi N., Nomoto S., Inoue S., et al. Early detection of liver failure after hepatectomy by indocyanine green elimination rate measured by pulse dye-densitometry. J Hepatobiliary Pancreatic Surg 13 (2006) 543-548
34. Aoki T., Yasuda D., Shimizu Y., Odaira M., Niiya T., Kusano T., et al. Image-guided liver mapping using fluorescence navigation system with indocyanine green for anatomical hepatic resection. World J Surg 32 (2008) 1763-1767
35. Erdogan D., Heijnen E.D., Bennink R.J., Dinant S., Straatsburg I.H., Gouma D.J., et al. Preoperative assessment of liver function: a comparison of 99-Tc-mebrofenin scintigraphy with indocyanine green clearance test. Liver Int 24 (2004) 117-123
36. Ishikawa M., Yogita S., Miyake H., Fukuda Y., Harada M., Wada M., et al. Clarification of risk factors for hepatectomy in patients with hepatocellular carcinoma. Hepatogastroenterology 49 (2002) 1625-1631
37. Iwata T., Inoue K., Nishiyama N., Nagano K., Izumi N., Tsuikioka T., et al. Factors predicting early postoperative liver cirrhosis-related complications after lung cancer surgery in patients with liver cirrhosis. Interact Cardiovasc Thorac Surg 6 (2007) 720-730
38. Lau H., Man K., Fan S.T., Yu W.C., Lo C.M., and Wong J. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 84 (1997) 1255-1259
39. Lee C.F., Yu M.C., Kuo L.M., Chan K.M., Jan Y.Y., Chen M.F., et al. Using indocyanine green test to avoid post-hepatectomy liver dysfunction. Chang Gung Med J 30 (2007) 333-338
40. Ohwada S., Kawate S., Hamada K., Yamada T., Sunrose Y., Tsutsumi H., et al. Perioperative real-time monitoring of indocyanine green clearance by pulse spectrophotometry. Br J Surg 93 (2006) 339-346
41. Okochi O., Kaneko T., Surgimoto T., Inoue S., Takeda S., and Nakao A. ICG pulse spectrophotometry for perioperative liver function in hepatectomy. J Surg Res 103 (2002) 109-113
42. Sawada T., Kita J., Nagata H., Shimoda M., and Kubota K. Hepatectomy for metastatic liver tumour in patients with liver dysfunction. Hepatogastroenterology 54 (2007) 2306-2309
43. Shimada K., Sakamoto Y., Esaki M., Kosuge T., Morizane C., Ikeda M., et al. Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 14 (2007) 2337-2347
44. Thasler W.E., Bein T., and Jauch K.W. Perioperative effects of hepatic resection surgery on hemodynamics, pulmonary fluid balance, and indocyanine green clearance. Langenbeck's Arch Surg 387 (2002) 271-275
45. Zoedler T., Ebener C., Becker H., and Roeher H.D. Evaluation of liver function tests to predict operative risk in liver surgery. HPB Surg 9 (1995) 13-18
46. Imamura H., Sano K., Sugawara Y., Kokudo N., and Makuuchi M. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreatic Surg 12 (2005) 16-22
47. Ashwell G., and Harford J. Carbohydrate-specific receptors of the liver. Annu Rev Biochem 51 (1982) 531-554
48. Kinoshita K., Ukikusa M., Iwaisako K., Arimoto A., Fujisawa N., Ozaki T., et al. Preoperative assessment of hepatic function: utility of a new convenient two-compartment model analysis using galactosyl human serum albumin scintigraphy. J Gastroenterol Hepatol 18 (2003) 99-104
49. Kwon A., Matsui Y., Kaibora M., and Ha-Kawa S.K. Preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin (GSA-Rmax) is useful for judging the safety of hepatic resection. Surgery 140 (2006) 379-386
50. Zuckerman E., Slobodin G., Sabo E., Yeshuran D., Naschitz J.E., and Groshar D. Quantitative liver-spleen scan using single photon emission computerised tomography (SPECT) for assessment of liver function in cirrhotic patients. J Hepatol 39 (2003) 326-332
51. Satoh K., Yamamoto Y., Nishiyama Y., Wakabayashi H., and Ohkawa M. 99m-Tc-GSA liver dynamic SPECT for the preoperative assessment of hepatectomy. Ann Nucl Med 17 (2003) 61-67
52. Bennink R.J., Dinanat S., Erdogan D., Heijnen E.D., Straatsburg I.H., van Vliet A.K., et al. Preoperative assessment of postoperative liver function using hepatobiliary scintigraphy. J Nucl Med 45 (2004) 965-971
53. Fujioka H., Kawashita Y., Kamohara Y., and Yamashita A. Utility of technetium-99m-labeled-galactosyl human serum albumin scintigraphy for estimating the hepatic functional reserve. J Clin Gastroenterol 28 (1999) 329-333
54. Kokudo N., Vera D.R., Koizumi M., Seki M., Sato T., Stadalnik R.C., et al. Recovery of hepatic asialoglycoprotein receptors after major hepatic resection. J Nucl Med 40 (1999) 137-141
55. Kokudo N., Vera D.R., Tada K., Koizumi M., Seki M., Matsubara T., et al. Predictors of successful hepatic resection: prognostic usefulness of hepatic asialoglycoprotein receptor analysis. World J Surg 26 (2002) 1342-1347
56. Kwon A., Ha-Kawa S.K., Uetsuji S., Inoue K., Matsui Y., and Kamiyama Y. Preoperative determination of the surgical procedure for hepatectomy using technetium-99m-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy. Hepatology 25 (1997) 426-429
57. Kwon A., Matsui Y., Ha-Kawa S.K., and Kamiyama Y. Functional hepatic volume measured by technetium-99m-galactosyl-human serum albumin liver scintigraphy: comparison between hepatocyte volume and liver volume by computed tomography. Am J Gastroenterol 96 (2001) 541-546
58. Kwon A.H., Ha-Kawa S.K., Uetsuji S., Kamiyama Y., and Tanaka Y. Use of technetium 99m diethylenetriamine-pentaacetic acid-galactosyl-human serum albumin liver scintigraphy in the evaluation of preoperative and postoperative hepatic functional reserve for hepatectomy. Surgery 117 (1995) 429-434
59. Tanaka A., Shinohara H., Hatano E., Sato S., Kanazawa A., Yamaoka Y., et al. Perioperative changes in hepatic function as assessed by asialoglycoprotein receptor indices by technetium 99m galactosyl human serum albumin. Hepatogastroenterology 46 (1999) 369-375
60. Yumoto Y., Umeda M., Ohsima K., Ogawa H., Kurokawa T., Kajitani M., et al. Estimation of remnant liver function before hepatectomy by means of technetium-99m-diethylenetriamine-pentaacetic acid galactosyl human albumin. Cancer Chemother Pharmacol 33 (1994) S1-S6
61. Kwon A., Matsui Y., Ha-Kawa S.K., and Kamiyama Y. Functional hepatic volume measured by technetium-99-galactosyl-human serum albumin liver scintigraphy: comparison between hepatocyte volume and liver volume by computed tomography. Am J Gastroenterol 96 (2004) 541-546
62. Kadono J., Kunemura H., Nishida S., Nakamura N., Gejima K., Nakajo M., et al. 99mTc-DTPA-galactosyl-human-serum-albumin liver scintigraphy for evaluating hepatic functional reserve before hepatectomy in a patient with indocyanine green excretory deficit: report of a case. Surg Today 36 (2006) 481-484
63. Li X.F., Kinuya S., Higuchi T., Konishi S., Hwang H.E., Shuke N., et al. Asialoglycoprotein receptor concentration in tumour-bearing livers and its fate early after their sectorial resection. Ann Nucl Med 17 (2003) 489-493
64. Bargetzi M.J., Aoyama T., Gonzalez F.J., and Meyer U.A. Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA. Clin Pharmacol Ther 46 (1989) 521
65. Oellerich M., Radue E., and Burdelski M. Lignocaine metabolism formation as a measure of pre-transplant liver function. Lancet 1 (1989)
66. Wojcicki J., Kowzlowski K., Drozdzik M., and Wojcicki M. Lidocaine elimination in patients with liver cirrhosis. Acta Pol Pharm 59 (2002) 321-324
67. Conti F., Dousset B., Cherruau B., Guerin C., Soubrane O., Houssin D., et al. Use of lidocaine metabolism to test liver function during the long-term follow-up of liver transplant recipients. Clin Transpl 18 (2004) 235-241
68. Lorf T., Schnitzbauer A., Schaefer S.K., Scherer M.N., Schlitt H.J., Oellerich M., et al. Prognostic value of monoethylglycinexylidide (MEGX)-test prior to liver resection. Hepatogastroenterology 55 (2008) 539-543
69. Ravaioli M., Grazi G.L., Principe A., Ercolani G., Cescon M., Gardini A., et al. Operative risk by the lidocaine test (MEGX) in resected patients for HCC on cirrhosis. Hepatogastroenterology 50 (2003) 1552-1555
70. Merckel C., Gatta Z., Zoli M., Bolognesi M., Angeli P., Lervese T., et al. Prognostic value of galactose elimination capacity, aminopyrine breath test and ICG clearance in patients with cirrhosis. Comparison with the Pugh score. Digest Dis Sci 36 (1991) 1197-11203
71. Redaelli C.A., Dufour J., Wagner M., Schilling M., Husler J., Krahenbuhl L., et al. Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg 235 (2002) 77-85
72. Fabbri A., Bianchi G., Brizi M., Zoli M., and Marchesini G. Uncertainty in liver function assessment on the basis of single-point galactose concentration. Digestion 58 (1997) 379-383
73. Katsuramaki T., Mizuguchi T., Kawamoto M., Yamaguchi K., Meguro M., Nagayama M., et al. Assessment of nutritional status and prediction of postoperative liver function from serum apolioprotein A-1 levels with hepatectomy. World J Surg 30 (2006) 1886-1891
74. Mizuguchi T., Katsuramki T., Nobuoka T., Kawamoto M., Oshima H., Kawasaki H., et al. Serum hyaluronate level for predicting subclinical liver dysfunction after hepatectomy. World J Surg 28 (2004) 971-976
75. Yachida S., Wakabayashi H., Kokudo N., Goda F., Okada S., Maeba T., et al. Measurement of serum hyaluronate as a predictor of human liver failure after major hepatectomy. World J Surg 24 (2000) 359-364
76. Mehta P., Ploutz-Snyder R., Nandi J., Rawlins S.R., Sanderson S.O., and Levine R.A. Diagnostic accuracy of serum hyaluronic acid, FIBROSpect II, and UKL-40 for discriminating fibrosis stages in chronic hepatitis. Am J Gastroenterol 103 (2008) 928-936
77. Ogata T., Okuda K., Ueno N., Saito N., and Aoyagi S. Serum hyaluronan as a predictor of hepatic regeneration after hepatectomy in humans. Eur J Clin Invest 29 (1999) 780-785
78. Nanashima A., Yamaguchi H., Shibaski S., Sawai T., Yamaguchi H., Yasutake T., et al. Measurement of serum hyaluronic acid level during the perioperative period of liver resection for evaluation of functional liver reserve. J Gastroenterol Hepatol 16 (2001) 1158-1163
79. Nanashima A., Yamaguchi H., Tanaka A., Shibaski S., Tsuji T., Ide N., et al. Preoperative serum hyaluronic acid level as a good predictor of posthepatectomy complications. Surg Today 34 (2004) 913-919
80. Suehiro S., Matsumata T., Shikada Y., Shimada H., Shirabe K., and Sugimachi K. Preoperative hyaluronic acid measurement to assess the hepatic functional reserve. Hepatogastroenterology 51 (2004) 1776-1779
81. Kusaka K., Harahara Y., Trozilli G., Kubota K., Takaayama T., Makuuchi M., et al. Objective evaluation of liver consistency to estimate hepatic fibrosis and functional reserve for hepatectomy. J Am Coll Surg 19 (2000) 47-53
82. Bruix J., Castells A., Bosch J., Feu F., Fuster J., Garcia-Pagan J.C., et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 111 (1996) 1018-1022
83. Annet L., Materne R., Danse E., Jamart J., Horsmans Y., and Van Beers B. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 229 (2003) 409-414
84. Lim A.K., Patel N., Eckersley R.J., Kuo Y., Goldin R.D., Thomas H.C., et al. Can Doppler sonography grade the severity of hepatitis C-related liver disease?. Am J Roentol 184 (2005) 1848-1853
85. Kuroki S., Naito T., Okamoto S., Sakai H., Yamashita H., Yamashita H., et al. Cholestyramine loading test to assess hepatic reserve for bile acid synthesis in patients with chronic liver disease. Gastroenterology 112 (1997) 1277-1283
86. Higashi S., Tabata N., Kondon K.H., Kai M., Miyamoto K., and Setoguchi T. A predominant increase of arterial beta-hydroxybutyrate concentration during partial hepatectomies in patients with impaired indocyanine green clearance test. J Surg Res 81 (1999) 243-248
87. Yamanaka N., Shimizu S., Chijiiwa K., Nishiyama K., Noshiro H., Yamaguchi H., et al. Hepatectomy and marked retention of indocyanine green and bromosulfophtalein. Hepatogastroenterology 48 (2001) 1450-1452
88. Kishikawa Y.K., Suehrio T., Niahizaki T., Shamida M., Itasaka H., and Nomoto K. Partial hepatic grafting: porcine study on critical volume reduction surgery. Surgery 118 (1995) 486-491
89. Man K., Lo C.M., Ng I.O., Wong Y.C., Qin L.F., and Fan S.T. Liver transplantation in rats using small-for-size grafts: a study of haemodynamic and morphological changes. Arch Surg 136 (2001) 280-285
90. Kiuchi T., Kasahara M., Uryuhama K., Inomata Y., Uemoto S., and Asnouman K. Impact of graft mismatching on graft prognosis in liver transplantation from living donors. Transplantation 67 (1999) 321-327
91. Eipel C., Glanemann M., Nuessler A.K., Menger M.D., Neuhaus P., and Vollmar B. Ischemic preconditioning impairs liver regeneration in extended reduced-size livers. Ann Surg 241 (2005) 477-484
92. Nolan J.P. Endotoxin, reticuloendothelial function and liver injury. Hepatology 1 (1981) 458-465
93. Roelofsen H., van der Veere C.N., Ottenhoff R., Schoemaker B., Jansen P.L., and Oude Elferenk R.P. Decreased bilirubin transport in the perfused liver of endotoxemic rats. Gastroenterology 107 (1994) 1075-1084
94. Akita K., Okuno M., Enya M., Imai S., Moriwaki H., Kawada N., et al. Impaired liver regeneration in mice by lipopolysaccheride via TNF-alpha/kallikrein-mediated activation of latent TGF-beta. Gastroenterology 123 (2002) 352-364
95. Yoshimoto N., Togo S., Kuboto T., Kammiukai N., Saito S., Nagano Y., et al. Role of transforming growth factor-beta (TGF-beta1) in endotoxin-induced hepatic failure after extensive hepatectomy in rats. J Endotoxin Res 11 (2005) 33-39
96. Nakano K., Chiiiwa K., and Tanaka K. Lower activity of CCAAT/enhancer-binding protein and expression of cyclin E, but not cyclin D1, activation protein-1 and p21 (WAF1) after partial hepatectomy in obstructive jaundice. Biochem Biophys Res Commun 280 (2001) 640-645
97. Wang D.S., Dou K.F., Li K.Z., Gao Z.Q., Song Z.S., and Liu Z.C. Hepatocellular apoptosis after hepatectomy in obstructive jaundice in rats. World J Gastroenterol 9 (2003) 2737-2741
98. Kamiaya S., Nagino M., Kanazawa H., Komatsu S., Mayumi T., and Takagi K. The value of bile replacement during external biliary drainage: an analysis of intestinal permeability, integrity and microflora. Ann Surg 239 (2004) 510-517
99. Kanda H., Nimura Y., Yasui A., Uematsu T., Kamiaya S., and Machiki Y. Hepatic blood flow after acute biliary obstruction and drainage in conscious dogs. Hepatogastroenterology 43 (1996) 235-240
100. Tsukamoto S., Nakata R., and Kojo S. Effect of aging on rat liver regeneration after partial hepatectomy. Biochem Mol Biol Int 30 (1993) 773-778
101. Beyer H.S., Sherman R., and Zieve L. Aging is associated with reduced liver regeneration and diminished thymidine kinase mRNA content and enzyme activity in the rat. J Lab Clin Med 117 (1990) 101-108
102. Little S.A., Jarnagin W.R., DeMattteo R.P., Blumgart L.H., and Fong Y. Diabetes is associated with increased preoperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer. J Gastrointest Surg 6 (2002) 88-94
103. van den Broek M.A., Damink S.W., Dejong C.H., Lang H., Malago M., Jalan R., et al. Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int 28 (2008) 767-780
104. Mullen J.T., Ribero D., Reddy S.K., Donadon M., Zorzi D., Gautam S., et al. Hepatic insufficiency and mortality in 1,059 non-cirrhotic patients undergoing major hepatectomy. J Am Coll Surg 204 (2007) 854-862